GlassScriptPhysician profile
William Dungan
NPI 1306460910
$4,724.20
in general payments reported to CMS, 2019-2025
18 companies · $852 in 2025
The $852 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $244 · 2024: $3,628 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,905 · Travel and Lodging: $1,720 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,904.76 |
| Travel and Lodging | $1,720.44 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Enterra Medical, INC. | $2,473.99 | 2024 | |
| Abbvie INC. | $1,059.24 | 2023-2025 | Skyrizi, Rinvoq |
| Takeda Pharmaceuticals U.S.A., INC. | $266.30 | 2023-2025 | Entyvio, Gattex, Eohilia |
| Janssen Biotech, INC. | $169.87 | 2023-2025 | Stelara, Tremfya |
| Pfizer INC. | $122.98 | 2024-2025 | |
| Genzyme Corporation | $113.96 | 2024-2025 | |
| Erbe USA INC | $90.00 | 2024-2025 | Vio3 |
| Regeneron Healthcare Solutions, INC. | $89.23 | 2024-2025 | Dupixent |
| Evoke Pharma, INC. | $55.39 | 2024 | |
| Lilly USA, LLC | $47.84 | 2024-2025 | Omvoh |
| Ardelyx, INC. | $47.51 | 2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.49 | 2023-2024 | Trulance, Xifaxan |
| Phathom Pharmaceuticals, INC. | $38.81 | 2024-2025 | Voquezna |
| Gilead Sciences, INC. | $34.83 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $21.33 | 2024 | Dificid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $19.16 | 2025 | |
| Exact Sciences Corporation | $14.18 | 2023 | Cologuard Collection Kit |
| Olympus America INC. | $14.09 | 2024 | Evis Exera III Colonovideoscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dungan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.